Kidney Int Suppl (2011). 2011 Sep; 1(3): 6367.
1Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
1Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
2Postgraduation Program in Genetic and Molecular Diagnosis, Universidade Luterana do Brasil, Canoas, Brazil
1Department of Genetics, Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil
2Postgraduation Program in Genetic and Molecular Diagnosis, Universidade Luterana do Brasil, Canoas, Brazil
Stem cells are defined as precursor cells that have the capacity to self-renew and to generate multiple mature cell types. Only after collecting and culturing tissues is it possible to classify cells according to this operational concept. This difficulty in identifying stem cells in situ, without any manipulation, limits the understanding of their true nature. This review aims at presenting, to health professionals interested in this area, an overview on the biology of embryonic and adult stem cells, and their therapeutic potential.
Keywords: adult stem cells, biological characteristics, cell therapy, embryonic stem cells, human diseases
Although the initial concept of stem cells is more than 100 years old,1 and much of its biology and therapeutic potential has been explored in the past three decades, we still know little about their true nature. This review is intended to provide an overview on the biology of stem cells and their therapeutic potential to those interested in this field.
Stem cells are operationally defined as cells that have the potential for unlimited or prolonged self-renewal, as well as the ability to give rise to at least one type of mature, differentiated cells.2, 3 Although this basic definition of stemness' applies generally to stem cells, it is necessary to individually consider embryonic and adult stem cells as they do not share much more than the name and the basic definition above.
In humans, the embryo is defined as the organism from the time of implantation in the uterus until the end of the second month of gestation. Embryonic stem cells (ESCs), however, refer to a much more restricted period, resulting from the isolation and cultivation of cells from the blastocyst, which forms at approximately 5 days after fertilization.4
The zygote, which is the cell resulting from the fertilization of an oocyte by a spermatozoon, is totipotent. Several successive cell divisions generate the morula, with 3264 totipotent cells. After that stage, it develops into the blastocyst, which consists of a hollow ball of cells. Peripheral cells (the trophoblast) of the blastocyst generate the embryonic membranes and placenta, whereas the inner cell mass develops into the fetus. These are the cells that are used to establish stem cell cultures (). They are not totipotent, as they do not have the ability to support the formation of another embryo, and are considered to be pluripotent as they can produce all the cell types of the adult organism. Further development of the embryo leads to the formation of the gastrula, composed of the three germ layers (ectoderm, mesoderm, and endoderm), from which the complete organism develops.
Embryonic stem cell cultivation. The zygote undergoes successive mitotic divisions until a sphere of cellsthe blastocystis formed. In the blastocyst, the trophoblast at its periphery generates the embryonic membranes and placenta, whereas the inner cell mass develops into the fetus. Embryonic stem cells are immortal in culture, having been established from one pluripotent cell collected from the inner cell mass. These are capable of differentiating into any of the mature cell types present in the adult organism.
In 1981, two groups established the first ESC lines from mouse blastocysts, and in 1998 the first human ESC line was generated.5 Although seemingly simple, the procedure is technically demanding because of the need for strictly controlled conditions necessary for the maintenance of the cells in the undifferentiated state. This is particularly important for human ESCs.6 Once established, ESC lines may be maintained in permanent culture, frozen and thawed, and transported between laboratories. It is estimated that there are currently around 250 human ESC lines in the world, widely shared among different groups. The process of establishing an ESC line requires, however, the destruction of the blastocyst, raising ethical issues as scientific investigation alone is not capable of determining whether blastocysts constitute human beings. An alternative method involves the production of ESCs by collection of only one cell from the inner cell mass, allowing implantation of the remaining cells in the womb. However, ethical considerations still remain as it has to be tested whether the remaining cells can develop into a normal human being.
Cultured ESCs show defined characteristics: they are pluripotent, capable of differentiating into cells derived from all three germ layers; they are immortal in culture and may be maintained for several hundred passages in the undifferentiated state; and they maintain a normal chromosomal composition.
Molecular characterization of ESCs is well developed, and they are known to express surface markers such as CD9, CD24, and alkaline phosphatase, and several genes involved with pluripotency, including Oct-4, Rex-1, SOX-2, Nanog, LIN28, Thy-1, and SSEA-3 and -4.7 Expression of high levels of telomerase explains their immortality in culture.
ESC research focuses mainly on two issues, both of which have shown significant progress in the past few years.6 The first point explores how to better maintain the cells in long-term culture, without significant modifications of their genetic composition and, in the case of human ESCs, avoiding the need for animal products in the culture. Generally, the cells are maintained in culture on feeder cells such as mouse fibroblasts. The second point focuses on how to differentiate the cells into the many mature cell types that are necessary for the potential treatment of different diseases. ESCs can be induced to differentiate into various cell types in suspension culture, resulting in three-dimensional cell aggregates called embryoid bodies. This tendency of ESCs to differentiate spontaneously may not always be desirable. A technical challenge is to control the differentiation process: although the addition of growth factors directs the differentiation process, usually the cultures spontaneously differentiate into various cell types. It is thus necessary to use methods that allow removal of undifferentiated ESCs from cultures in which the differentiated cell types are the desired product.
Recently, methods for direct reprogramming of adult cells to induced pluripotent stem cells have been developed.8 In the process, mature cells from the patient are treated in vitro with genes that dedifferentiate' them to a pluripotent stage, similar to an ESC (). Induced pluripotent stem cells are believed to be identical to natural pluripotent ESCs in many respects, including the expression of specific genes and proteins, chromatin methylation patterns, culture kinetics, in vitro differentiation patterns, and teratoma formation. Besides avoiding the ethical issues associated with the destruction of human embryos, this approach allows the generation of patient-specific cells of any lineage. Problems related to the genetic modification of target cells, however, must still be resolved before induced pluripotent stem cells may be clinically tested.
Production of induced pluripotent stem (iPS) cells. iPS cells are produced by treating mature cells, such as fibroblasts, with genes that dedifferentiate' them to a pluripotent stage, similar to an embryonic stem cell. Viral vectors, such as retroviruses, are generally used for gene transfer. The transformed cells become morphologically and biochemically similar to pluripotent stem cells, with the advantage of representing autologous cells in therapeutic applications.
The principal advantage of ESCs over adult stem cells is related to their pluripotency and limitless expansion in culture, as they have the potential to give rise to all cell types composing the adult organism. This potential is exploited in vitro to develop specialized cells that are then used in therapy.
Owing mainly to safety issues, the clinical use of hESCs is much more restricted than that of adult stem cells. As proof of pluripotency, ESC lineages injected into immunodeficient mice must lead to teratoma formation, with derivatives of all three germ layers. Only differentiated cells derived from ESCs may be administered to patients, as any contaminating undifferentiated cells could give rise to cancer. The first clinical trial using human ESC-derived cells, which in this case are oligodendrocyte progenitor cells, was started in October 2010. Care must be taken, however, to not call this procedure human ESC therapy', as the cells to be used are no longer ESCs.
See the original post here:
Biology of stem cells: an overview - PMC - National Center for ...
- New Atlas of Rare Stem and Progenitor Cells Reveals New Cell Types - Inside Precision Medicine - March 28th, 2024
- Instructing iPS cell-derived mesenchymal stem cells to inhibit abnormal bone formation in FOP - Medical Xpress - March 28th, 2024
- GLP podcast: GE crops have lived up to the hype; Growing 'mini' organs from stem cells; How do we solve right-wing ... - Genetic Literacy Project - March 28th, 2024
- Exosomes and Stem Cells Are the Future of Anti-Aging - NewBeauty Magazine - March 28th, 2024
- Stem cells: past, present, and future - PMC - National Center for ... - March 19th, 2024
- Stem cells: a comprehensive review of origins and emerging clinical ... - March 19th, 2024
- What are Stem Cells? - Types, Applications and Sources - BYJU'S - March 19th, 2024
- Stem Cell - The Definitive Guide | Biology Dictionary - March 19th, 2024
- Colossal Creates Elephant Stem Cells for the First Time in Quest to Revive the Woolly Mammoth - Singularity Hub - March 19th, 2024
- Florida congresswoman sued the Pentagon over stem cells. One problem: her husband's stocks - Raw Story - January 23rd, 2024
- Can Stem Cells Improve Knee Pain or Are They A Waste of Money? - Bloomberg - January 23rd, 2024
- Stem cells used to successfully treat arthritis in gorilla at Budapest zoo - University of Sheffield News - January 23rd, 2024
- A computational model of stem cells' internal mechanism to recapitulate spatial patterning and maintain the self ... - Nature.com - January 23rd, 2024
- Advancing the generation of in-vivo chimeric lungs in mice using rat-derived stem cells - EurekAlert - January 6th, 2024
- 'I couldn't just give up on my dad' | Round Rock son donates stem cells to father battling leukemia - KVUE.com - January 6th, 2024
- Closing in on the ultimate quest to regenerate insulin in pancreatic stem cells - Medical Xpress - January 6th, 2024
- Ask the doctors: Research being conducted on using stem cells to treat diabetes - The Spokesman Review - January 6th, 2024
- Regenerative Medicine and COPD: Generating Functional Lungs from Pluripotent Stem Cells - Medriva - January 6th, 2024
- What is a stem cell? YourGenome - December 2nd, 2023
- Stem cell transplant - NHS - December 27th, 2022
- Stem cells: a brief history and outlook - Science in the News - December 27th, 2022
- RUDN Physician And Russian Scientists Investigate Long-term Effects Of Treating Diabetic Ulcers With Stem Cells - India Education Diary - December 27th, 2022
- Stem Cell Basics | STEM Cell Information - National Institutes of Health - December 2nd, 2022
- Neural stem cell - Wikipedia - November 24th, 2022
- Donate Stem Cells | Bone Marrow Donation - American Cancer Society - November 24th, 2022
- Stem Cells- Definition, Properties, Types, Uses, Challenges - November 6th, 2022
- Brothers from Karnataka, Prapul and Prajwal donated their stem cells, save two blood cancer patients - APN News - November 6th, 2022
- Getting These Stem Cells Treatments: Crippled Ronnie Coleman Gives a Positive Update on His Ability to Walk - EssentiallySports - October 21st, 2022
- Cornell Prof Explains Relevance of Creating Mouse Embryos from Stem Cells - Cornell University The Cornell Daily Sun - October 13th, 2022
- Human neuron clusters transplanted into rats offer new tool to study the brain : Shots - Health News - NPR - October 13th, 2022
- The neuroprotective effects of dental pulp stem cells and erythropoietin in mice hippocampus after ischemia-reperfusion - Newswise - October 13th, 2022
- A $7 million grant to grow stem cell research - Swinburne University of Technology - October 13th, 2022
- Stem Cell Manufacturing Global Market Report 2022: Widespread Product Utilization in Effective Disease Management, Personalized Medicine, and Genome... - October 13th, 2022
- Brennand named Elizabeth Mears and House Jameson Professor of Psychiatry - Yale News - October 13th, 2022
- American Academy of Stem Cell Physicians to Offer Licensed Physicians Board Examination in Regenerative Medicine - BioSpace - October 13th, 2022
- Stem Cells - alsa.org - October 4th, 2022
- Mouse embryo models built from stem cells take shape in a dish - Nature.com - October 4th, 2022
- Growth in Cell and Gene Therapy Market - Pharmaceutical Technology Magazine - October 4th, 2022
- Therapeutic Solutions International Identifies CD103 Expressing Dendritic Cells and Exosomes Thereof as Novel Mechanism for JadiCell Mesenchymal Stem... - October 4th, 2022
- Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from... - October 4th, 2022
- Research Shows Promise for Directing Later Lines of Therapy for Hodgkin Lymphoma - Targeted Oncology - October 4th, 2022
- Hereditary E200K mutation within the prion protein gene alters human iPSC derived cardiomyocyte function | Scientific Reports - Nature.com - September 25th, 2022
- How To Eat Your Way to Better Health According to a Doctor - Eat This, Not That - September 25th, 2022
- Phio Pharmaceuticals Announces Preclinical Data Demonstrating PH-762 Enhances Persistence of T cells for Tumor Cell Killing as Presented by Helmholtz... - September 25th, 2022
- Types of blood cancer: Leukemia, lymphoma, and more - Medical News Today - September 25th, 2022
- September: er-blood | News and features - University of Bristol - September 25th, 2022
- Here Is Why You Heal Slower As You Age - Health Digest - September 25th, 2022
- Global Single Cell Analysis Market is Projected to Grow at a CAGR of 15.1% By 2032: Visiongain Reports Ltd - Yahoo Finance UK - September 25th, 2022
- Findings explain exceptional auditory abilities in Williams-Beuren Syndrome - EurekAlert - September 25th, 2022
- Finding the potency in planarians | Communications Biology - Nature.com - September 16th, 2022
- Life-Saving Innovations in Cancer-Fighting Stem Cell Transplants and Pioneering Research in HIV, Autism and Cerebral Palsy to be Featured at World... - September 16th, 2022
- Treating Cancer with Oncolytic Viruses - BioPharm International - September 16th, 2022
- Israel's Profuse Technology Raises $2.5M for Technology That Lowers Cost of Cultured Meat - The Spoon - September 16th, 2022
- Stem Cells Used to Grow Mouse Embryo - BioTechniques - September 8th, 2022
- Largest Gift in UCSD History to Fund Stem Cell Research on Space Station - Times of San Diego - September 8th, 2022
- Global Induced Pluripotent Stem Cells Market (2022 to 2027) - Growth, Trends, Covid-19 Impact and Forecasts - ResearchAndMarkets.com - Business Wire - September 8th, 2022
- Health on the Frontlines: The Healing Power of Stem Cells - Dans Papers - September 8th, 2022
- Top 3 grants in regenerative medicine: July 2022 - RegMedNet - September 8th, 2022
- Childhood leukemia treatment 2022: Where we are now and what it takes - EurekAlert - September 8th, 2022
- Treatment Choices for AML Were Increasingly Influenced by Immunological Responses - Physician's Weekly - September 8th, 2022
- BioRestorative Therapies to Present at the H.C. Wainwright 24th Annual Global Investment Conference on September 14 - StreetInsider.com - September 8th, 2022
- Global Recombinant Cell Culture Supplements Market Report 2022: Increasing Need for Immunotherapies and Stem Cell and Regenerative Medicines Presents... - September 8th, 2022
- CAR-T Beyond CGTs In Development In 2022 - BioProcess Online - September 8th, 2022
- ADOCIA Announces First Cell Therapy Preclinical Proof of Concept of AdoShell Islets for the Treatment of Type 1 Diabetes - Business Wire - September 8th, 2022
- Synthetic Mouse Embryo with Brain and Beating Heart Grown from Stem Cells - Genetic Engineering & Biotechnology News - August 30th, 2022
- Utilization of Modified Induced Pluripotent Stem Cells as the Advance | OPTH - Dove Medical Press - August 30th, 2022
- Rise In Number Of CROS In Various Regions Such As Europe Is Expected To Fuel The Growth Of Induced Pluripotent Stem Cell Market At An Impressive CAGR... - August 30th, 2022
- Brush Up: Hematopoietic Stem Cells and Their Role in Development and Disease Therapy - The Scientist - August 30th, 2022
- Regenerative Properties of the Newborn Heart Offers Hope for Those With Congenital Heart Disease - The Epoch Times - August 30th, 2022
- Kanpur hospital is Indias first to perform fat-derived stem cell transplant for diabetic patients - India Today - August 30th, 2022
- Scientists Just Genetically Edited a Million Years of Evolution Into Mouse DNA - ScienceAlert - August 30th, 2022
- Canadian Blood Services Stem Cells for Life - August 22nd, 2022
- Scientists say they have created 'embryos' without sperm or eggs - Medical News Today - August 22nd, 2022
- Many stem cell lines used for research and therapies carry large number of mutations, Cambridge researchers find - Cambridge Independent - August 22nd, 2022
- Scientists hope to revive extinct mammal through stem cells and gene-editing in a first - The Mirror - August 22nd, 2022
- Stem cell therapy in capsule form - Malaya - August 22nd, 2022
- Cell Culture Technician Pluripotent Stem Cell Biology and Genome Editing job with UNIVERSITY OF SOUTHAMPTON | 305107 - Times Higher Education - August 22nd, 2022
- Long COVID-19 and other chronic respiratory conditions after viral infections may stem from an overactive immune response in the lungs - The... - August 5th, 2022
- Self-organized anteroposterior regionalization of early midbrain and hindbrain using micropatterned human embryonic stem cells - Newswise - July 27th, 2022
- Synthetic Stem Cells Market 2022 Size, Share, Future Plans, Competitive Landscape and Forecast to 2030 This Is Ardee - This Is Ardee - July 27th, 2022